33.21
price down icon0.95%   -0.32
after-market Handel nachbörslich: 33.21
loading

Alkermes Plc Aktie (ALKS) Neueste Nachrichten

pulisher
Mar 29, 2025

(ALKS) Trading Report - Stock Traders Daily

Mar 29, 2025
pulisher
Mar 27, 2025

Deutsche Bank Adjusts Alkermes Public Price Target to $52 From $40, Maintains Buy Rating - Marketscreener.com

Mar 27, 2025
pulisher
Mar 27, 2025

What 5 Analyst Ratings Have To Say About Alkermes - Benzinga

Mar 27, 2025
pulisher
Mar 27, 2025

New National Survey of Healthcare Providers Offers Insights Into the Dynamic and Challenging Treatment Journey for People Living With Schizophrenia or Bipolar I Disorder - PR Newswire

Mar 27, 2025
pulisher
Mar 26, 2025

Will Alkermes' Proprietary Drugs Aid Growth Amid Stiff Competition? - MSN

Mar 26, 2025
pulisher
Mar 25, 2025

Mural Oncology stock plunges on trial halt (MURA:NASDAQ) - Seeking Alpha

Mar 25, 2025
pulisher
Mar 25, 2025

Liposomal Drug Delivery Market Detailed In New Research Report - openPR

Mar 25, 2025
pulisher
Mar 21, 2025

First Week of November 21st Options Trading For Alkermes (ALKS) - Nasdaq

Mar 21, 2025
pulisher
Mar 20, 2025

Controlled Release Drug Delivery Market to Witness Massive - openPR

Mar 20, 2025
pulisher
Mar 19, 2025

Alkermes price target raised to $35 from $34 at BofA - MSN

Mar 19, 2025
pulisher
Mar 18, 2025

Where are the Opportunities in (ALKS) - Stock Traders Daily

Mar 18, 2025
pulisher
Mar 15, 2025

Insider Sale at Alkermes PLC: EVP R&D, Chief Medical Officer Cra - GuruFocus.com

Mar 15, 2025
pulisher
Mar 14, 2025

Why Is Alkermes (ALKS) Down 6.6% Since Last Earnings Report? - Yahoo Finance

Mar 14, 2025
pulisher
Mar 14, 2025

Is Alkermes plc (ALKS) the Best Healthcare Stock For Long-Term Investment? - Insider Monkey

Mar 14, 2025
pulisher
Mar 14, 2025

Alkermes PLC Reports Q4 Revenue of $430 Million, Beating Estimat - GuruFocus.com

Mar 14, 2025
pulisher
Mar 14, 2025

Alkermes' (NASDAQ:ALKS) investors will be pleased with their splendid 140% return over the last five years - Yahoo Finance

Mar 14, 2025
pulisher
Mar 14, 2025

Alkermes (NASDAQ:ALKS) shareholders have earned a 19% CAGR over the last five years - Simply Wall St

Mar 14, 2025
pulisher
Mar 13, 2025

Alkermes Facing Near-Term Headwinds Across Existing Franchises, Royalties, RBC Says - Marketscreener.com

Mar 13, 2025
pulisher
Mar 13, 2025

RBC Capital Initiates Coverage of Alkermes (ALKS) with Sector Perform Recommendation - Nasdaq

Mar 13, 2025
pulisher
Mar 13, 2025

S&P 500 Futures Drop in Premarket Trading; Alkermes, Intel Lead - Barron's

Mar 13, 2025
pulisher
Mar 13, 2025

Alkermes initiated with a Sector Perform at RBC Capital - TipRanks

Mar 13, 2025
pulisher
Mar 13, 2025

Charles Schwab Investment Management Inc. Sells 38,088 Shares of Alkermes plc (NASDAQ:ALKS) - Defense World

Mar 13, 2025
pulisher
Mar 12, 2025

Alkermes at Leerink’s Global Healthcare Conference: Strategic Pipeline Insights - Investing.com India

Mar 12, 2025
pulisher
Mar 12, 2025

Alkermes at Leerink’s Global Healthcare Conference: Strategic Pipeline Insights By Investing.com - Investing.com South Africa

Mar 12, 2025
pulisher
Mar 12, 2025

Alkermes to Participate in Upcoming Investor Conferences - GuruFocus.com

Mar 12, 2025
pulisher
Mar 11, 2025

Mural Oncology Announces Fourth Quarter and Year End 2024 Financial Results and Highlights Upcoming Clinical Milestones - The Manila Times

Mar 11, 2025
pulisher
Mar 09, 2025

Alkermes Plc to Host Earnings Call - ACCESS Newswire

Mar 09, 2025
pulisher
Mar 09, 2025

Alkermes plc (NASDAQ:ALKS) Shares Bought by Smartleaf Asset Management LLC - Defense World

Mar 09, 2025
pulisher
Mar 09, 2025

Proficio Capital Partners LLC Buys New Stake in Alkermes plc (NASDAQ:ALKS) - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

(ALKS) Technical Pivots with Risk Controls - Stock Traders Daily

Mar 08, 2025
pulisher
Mar 08, 2025

What is Zacks Research’s Estimate for Alkermes Q1 Earnings? - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

Zacks Research Predicts Alkermes FY2027 Earnings - Defense World

Mar 07, 2025
pulisher
Mar 07, 2025

UBS Group Upgrades Alkermes (NASDAQ:ALKS) to Neutral - MarketBeat

Mar 07, 2025
pulisher
Mar 06, 2025

Y Intercept Hong Kong Ltd Invests $413,000 in Alkermes plc (NASDAQ:ALKS) - MarketBeat

Mar 06, 2025
pulisher
Mar 05, 2025

UBS Upgrades Alkermes (ALKS) - Nasdaq

Mar 05, 2025
pulisher
Mar 05, 2025

Bank of New York Mellon Corp Has $61.45 Million Stock Holdings in Alkermes plc (NASDAQ:ALKS) - Defense World

Mar 05, 2025
pulisher
Mar 05, 2025

Alkermes (NASDAQ:ALKS) Upgraded to Neutral at UBS Group - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

UBS Upgrades Alkermes to Neutral From Sell, $38 Price Target -March 04, 2025 at 08:27 am EST - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

Alkermes upgraded to Neutral from Sell at UBS - TipRanks

Mar 04, 2025
pulisher
Mar 01, 2025

Alkermes plc (ALKS): Among the Best Psychedelic Stocks to Buy in 2025 - Insider Monkey

Mar 01, 2025
pulisher
Mar 01, 2025

New York State Common Retirement Fund Increases Holdings in Alkermes plc (NASDAQ:ALKS) - Defense World

Mar 01, 2025
pulisher
Feb 28, 2025

Ieq Capital LLC Acquires New Stake in Alkermes plc (NASDAQ:ALKS) - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Alkermes VP Samuel Parisi sells $65,892 in shares - Investing.com India

Feb 28, 2025
pulisher
Feb 28, 2025

Alkermes VP Samuel Parisi sells $65,892 in shares By Investing.com - Investing.com UK

Feb 28, 2025
pulisher
Feb 28, 2025

Illinois Municipal Retirement Fund Sells 11,878 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat

Feb 28, 2025
pulisher
Feb 27, 2025

Alkermes plc (NASDAQ:ALKS) is HealthInvest Partners AB's 10th Largest Position - MarketBeat

Feb 27, 2025
pulisher
Feb 27, 2025

C WorldWide Group Holding A S Purchases Shares of 250,000 Alkermes plc (NASDAQ:ALKS) - MarketBeat

Feb 27, 2025
pulisher
Feb 27, 2025

Todd Asset Management LLC Sells 30,957 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat

Feb 27, 2025
pulisher
Feb 27, 2025

Sanctuary Advisors LLC Acquires 1,917 Shares of Alkermes plc (NASDAQ:ALKS) - Defense World

Feb 27, 2025
pulisher
Feb 26, 2025

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Alkermes plc To Contact The Firm - ACCESS Newswire

Feb 26, 2025
pulisher
Feb 26, 2025

Blue Trust Inc. Purchases 1,629 Shares of Alkermes plc (NASDAQ:ALKS) - Defense World

Feb 26, 2025
pulisher
Feb 25, 2025

Alkermes VP of finance Samuel Joseph Parisi sells shares worth $131,978 By Investing.com - Investing.com South Africa

Feb 25, 2025
pulisher
Feb 25, 2025

Alkermes VP of finance Samuel Joseph Parisi sells shares worth $131,978 - Investing.com India

Feb 25, 2025
pulisher
Feb 25, 2025

Trading (ALKS) With Integrated Risk Controls - Stock Traders Daily

Feb 25, 2025
pulisher
Feb 25, 2025

Alkermes’ Neuroscience Pivot: ALKS 2680 Set To Revolutionize Narcolepsy Treatment (ALKS) - Seeking Alpha

Feb 25, 2025
pulisher
Feb 24, 2025

Alkermes plc (NASDAQ:ALKS) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World

Feb 24, 2025
pulisher
Feb 24, 2025

Hussman Strategic Advisors Inc. Takes Position in Alkermes plc (NASDAQ:ALKS) - MarketBeat

Feb 24, 2025
$10.41
price down icon 3.70%
$96.16
price down icon 0.91%
$8.68
price down icon 1.81%
$113.16
price down icon 0.74%
$131.81
price up icon 0.05%
Kapitalisierung:     |  Volumen (24h):